E11.3319 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye

Name of the Condition

• Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye

Summary

Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye, is a condition where chronic high blood sugar levels cause damage to the retinal blood vessels, leading to moderate nonproliferative changes and swelling in the macula of an unspecified eye. This stage involves increased microaneurysms, dot-blot hemorrhages, hard exudates, and venous beading, with macular edema potentially affecting central vision. Ongoing monitoring and management are critical to prevent progression to more severe stages.

Causes

High blood sugar levels over time damage the retinal blood vessels, leading to moderate nonproliferative diabetic retinopathy and macular edema. Insulin resistance or insufficient insulin production in type 2 diabetes contributes to sustained hyperglycemia, which triggers vascular changes and fluid leakage in the retina. Metabolic factors, such as advanced glycation end products, also play a role in this ocular complication.

Risk Factors

• Poorly controlled blood glucose levels.
• Long duration of diabetes.
• Hypertension and dyslipidemia.
• Smoking.
• Obesity and sedentary lifestyle.

Symptoms

• Blurred or distorted central vision in the affected eye.
• Fluctuating vision.
• Presence of floaters or spots.
• Difficulty reading or recognizing faces.

Diagnosis

Diagnosis involves a comprehensive eye examination, including visual acuity testing, dilated retinal examination, and optical coherence tomography (OCT) to assess macular edema. Fluorescein angiography may be used to evaluate retinal blood vessel changes. Blood glucose and HbA1c levels are typically checked to confirm diabetes management status.

Treatment Options

Treatment focuses on controlling blood sugar, blood pressure, and lipid levels. Intravitreal anti-VEGF injections or corticosteroids may be used to reduce macular edema. Laser photocoagulation can address nonproliferative changes. Regular follow-up with an ophthalmologist is essential.

Prognosis and Follow-Up

With proper management, progression can be slowed, but vision loss may still occur. Follow-up typically includes regular eye exams every 6–12 months, or more frequently if changes are noted. Early intervention improves outcomes.

Complications

• Progression to severe nonproliferative or proliferative diabetic retinopathy.
• Permanent vision loss or blindness.
• Increased risk of other diabetic eye complications, such as cataracts or glaucoma.

Lifestyle & Prevention

• Maintain tight blood glucose control through diet, exercise, and medication.
• Manage blood pressure and cholesterol levels.
• Avoid smoking and limit alcohol intake.
• Regular physical activity and a balanced diet support overall diabetes management.

When to Seek Professional Help

Seek immediate care if you experience sudden vision changes, increased floaters, or vision loss, as these may indicate worsening retinopathy or other serious eye conditions.

Tips for Medical Coders

Document the eye laterality as "unspecified" when the specific eye is not documented. Ensure supporting documentation confirms the presence of moderate nonproliferative diabetic retinopathy with macular edema and type 2 diabetes. Code E11.3319 is appropriate when the eye is not specified.